|
Delayed
NYSE
19:56:46 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1707 USD | -3.56% |
|
+3.39% | -70.87% |
| 08-20 | Top Premarket Decliners | MT |
| 08-13 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MATINAS BIOPHARMA | Bio Therapeutic Drugs | -3.56% | +3.39% | -70.87% | -91.20% | -99.76% | 2.6M |  | | |
- Stock Market
- Stocks
- MTNB Stock
- Charts Matinas BioPharma
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
